US FDA concerned over potential Novavax myocarditis risk ...Middle East

Daily Sun - News
US FDA concerned over potential Novavax myocarditis risk
WASHINGTON: The Food and Drug Administration voiced concern Friday about myocarditis being potentially linked to the Novavax Covid-19 vaccine, just as experts are to weigh its use in the United States.The Novavax vaccine is already authorized in other countries, particularly in Europe. In the United States, an independent committee convened at the request of the FDA is to meet Tuesday to evaluate data from the clinical trials of Novavax and give its recommendation.In advance of that, the agency published a lengthy document on Friday analyzing these results, as it had done for the three other vaccines already authorized in the country.Shortly afterwards, Novavax stock dropped 20 percent on th

Hence then, the article about us fda concerned over potential novavax myocarditis risk was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA concerned over potential Novavax myocarditis risk )

Apple Storegoogle play

Last updated :

Also on site :